Neumora Therapeutics, Inc. NMRA Q4 2025 Annual earnings

FAQ

When did Neumora Therapeutics, Inc. report Q4 2025 earnings?

Neumora Therapeutics, Inc. (NMRA) reported Q4 2025 earnings on March 16, 2026 before market open.

What were Neumora Therapeutics, Inc.'s Q4 2025 revenue and EPS?

Neumora Therapeutics, Inc. reported eps of $-0.35 for Q4 2025.

Did Neumora Therapeutics, Inc. beat estimates in Q4 2025?

EPS missed the consensus estimate of $-0.34 by $0.01.

How did Neumora Therapeutics, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 5.4% from $-0.37.

Where can I find Neumora Therapeutics, Inc.'s Q4 2025 SEC filings?

You can read the 10-K periodic report (0001193125-26-130388) directly on SEC EDGAR. The filing index links above go to sec.gov.